238 related articles for article (PubMed ID: 34459127)
1. Apolipoprotein C-II induces EMT to promote gastric cancer peritoneal metastasis via PI3K/AKT/mTOR pathway.
Wang C; Yang Z; Xu E; Shen X; Wang X; Li Z; Yu H; Chen K; Hu Q; Xia X; Liu S; Guan W
Clin Transl Med; 2021 Aug; 11(8):e522. PubMed ID: 34459127
[TBL] [Abstract][Full Text] [Related]
2. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway.
Zeng L; Liao Q; Zou Z; Wen Y; Wang J; Liu C; He Q; Weng N; Zeng J; Tang H; Fang R; Lei Z; Tang Z; Yang X; Cui S
Cell Physiol Biochem; 2018; 51(3):1221-1236. PubMed ID: 30481766
[TBL] [Abstract][Full Text] [Related]
3. DDR2 Induces Gastric Cancer Cell Activities via Activating mTORC2 Signaling and Is Associated with Clinicopathological Characteristics of Gastric Cancer.
Wang YG; Xu L; Jia RR; Wu Q; Wang T; Wei J; Ma JL; Shi M; Li ZS
Dig Dis Sci; 2016 Aug; 61(8):2272-2283. PubMed ID: 27010547
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of ARK5 Expression Suppresses Invasion and Metastasis of Gastric Cancer.
Chen D; Liu G; Xu N; You X; Zhou H; Zhao X; Liu Q
Cell Physiol Biochem; 2017; 42(3):1025-1036. PubMed ID: 28662499
[TBL] [Abstract][Full Text] [Related]
5. ZNF143 enhances metastasis of gastric cancer by promoting the process of EMT through PI3K/AKT signaling pathway.
Wei S; Wang L; Zhang L; Li B; Li Z; Zhang Q; Wang J; Chen L; Sun G; Li Q; Xu H; Zhang D; Xu Z
Tumour Biol; 2016 Sep; 37(9):12813-12821. PubMed ID: 27449034
[TBL] [Abstract][Full Text] [Related]
6. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB
J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349
[TBL] [Abstract][Full Text] [Related]
7. Anthrax toxin receptor 1/tumor endothelial marker 8 promotes gastric cancer progression through activation of the PI3K/AKT/mTOR signaling pathway.
Cai C; Dang W; Liu S; Huang L; Li Y; Li G; Yan S; Jiang C; Song X; Hu Y; Gu J
Cancer Sci; 2020 Apr; 111(4):1132-1145. PubMed ID: 31977138
[TBL] [Abstract][Full Text] [Related]
8. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
[TBL] [Abstract][Full Text] [Related]
9. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
[TBL] [Abstract][Full Text] [Related]
10. CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway.
Zang M; Zhang B; Zhang Y; Li J; Su L; Zhu Z; Gu Q; Liu B; Yan M
PLoS One; 2014; 9(11):e112908. PubMed ID: 25398131
[TBL] [Abstract][Full Text] [Related]
11. Upregulated hsa_circRNA_100269 inhibits the growth and metastasis of gastric cancer through inactivating PI3K/Akt axis.
Wang Z; Liu C
PLoS One; 2021; 16(4):e0250603. PubMed ID: 33901239
[TBL] [Abstract][Full Text] [Related]
12. Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway.
Zhang X; Wang S; Wang H; Cao J; Huang X; Chen Z; Xu P; Sun G; Xu J; Lv J; Xu Z
Mol Cancer; 2019 Feb; 18(1):20. PubMed ID: 30717751
[TBL] [Abstract][Full Text] [Related]
13. LncRNA DLEU2 silencing impedes the migration, invasion and EMT in gastric cancer cell by suppressing PI3K/AKT signaling pathway.
Hu J; Wang M; Yang Y; Xing Y; Li S
Immunopharmacol Immunotoxicol; 2022 Oct; 44(5):719-731. PubMed ID: 35736813
[No Abstract] [Full Text] [Related]
14. NUCKS1 promotes gastric cancer cell aggressiveness by upregulating IGF-1R and subsequently activating the PI3K/Akt/mTOR signaling pathway.
Huang YK; Kang WM; Ma ZQ; Liu YQ; Zhou L; Yu JC
Carcinogenesis; 2019 Apr; 40(2):370-379. PubMed ID: 30371738
[TBL] [Abstract][Full Text] [Related]
15. Dickkopf-related protein 1/cytoskeleton-associated protein 4 signaling activation by
Luo M; Chen YJ; Xie Y; Wang QR; Xiang YN; Long NY; Yang WX; Zhao Y; Zhou JJ
World J Gastroenterol; 2022 Dec; 28(47):6769-6787. PubMed ID: 36620343
[TBL] [Abstract][Full Text] [Related]
16. Acacetin inhibits invasion, migration and TGF-β1-induced EMT of gastric cancer cells through the PI3K/Akt/Snail pathway.
Zhang G; Li Z; Dong J; Zhou W; Zhang Z; Que Z; Zhu X; Xu Y; Cao N; Zhao A
BMC Complement Med Ther; 2022 Jan; 22(1):10. PubMed ID: 35000605
[TBL] [Abstract][Full Text] [Related]
17. The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway.
Liu X; Xiao M; Zhang L; Li L; Zhu G; Shen E; Lv M; Lu X; Sun Z
J Clin Lab Anal; 2021 Mar; 35(3):e23655. PubMed ID: 33314339
[TBL] [Abstract][Full Text] [Related]
18. SPI1 Mediates N-Myristoyltransferase 1 to Advance Gastric Cancer Progression via PI3K/AKT/mTOR Pathway.
Qiu P; Li X; Gong M; Wen P; Wen J; Xu L; Wang G
Can J Gastroenterol Hepatol; 2023; 2023():2021515. PubMed ID: 36967718
[TBL] [Abstract][Full Text] [Related]
19. ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway.
Ye J; Huang J; Xu J; Huang Q; Wang J; Zhong W; Lin X; Li Y; Lin X
BMC Cancer; 2017 Sep; 17(1):626. PubMed ID: 28874138
[TBL] [Abstract][Full Text] [Related]
20. CYP2E1 changes the biological function of gastric cancer cells via the PI3K/Akt/mTOR signaling pathway.
Wang RY; Chen XW; Zhang WW; Jiang F; Liu MQ; Shen XB
Mol Med Rep; 2020 Feb; 21(2):842-850. PubMed ID: 31974627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]